INFLUENCE OF GLYCEMIC CONTROL ON CLOPIDOGREL RESPONSE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: A SUB-ANALYSIS FROM A RANDOMIZED, DOUBLE-BLIND STUDY

Background: Diabetes mellitus is a well-known risk factor for recurrent adverse cardiac events in patients taking dual antiplatelet therapy (DAPT) with aspirin and clopidogrel.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A1595-A1595
Main Authors: de Mendonca Furtado, Remo Holanda, Barbosa, Carlos, Strunz, Celia, Franci, Andre, Menezes, Fernando, Arantes, Flavia, Amico, Elbio D, Rocha, Tania Rubia Flores, Genestreti, Paulo, Nicolau, Jose
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Cardiovascular disease
Diabetes
Drug therapy
Glucose
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Diabetes mellitus is a well-known risk factor for recurrent adverse cardiac events in patients taking dual antiplatelet therapy (DAPT) with aspirin and clopidogrel.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)61595-9